Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Click Therapeutics, Inc.

Click Therapeutics Underscores Its Commitment to Innovation and Leadership in Software as Prescription Medical Treatments with Launch of New Brand Identity
From Click Therapeutics, Inc.
Via Business Wire
Click Therapeutics Launches Software-Enhanced Drug™ Therapies as Part of New Click SE™ Offering
From Click Therapeutics, Inc.
Via Business Wire
Click Therapeutics Founder and CEO David Benshoof Klein Named to 2024 PharmaVoice 100 List
From Click Therapeutics, Inc.
Via Business Wire
Click Therapeutics Announces CT-132 Met Primary Endpoint for the Reduction of Monthly Migraine Days in ReMMi-D Pivotal Trial
From Click Therapeutics, Inc.
Via Business Wire
Click Therapeutics Accelerates Expansion into Obesity and Cardiometabolic Disease With Acquisition of the Assets of Better Therapeutics, Inc.
From Click Therapeutics, Inc.
Via Business Wire
Click Therapeutics and Boehringer Ingelheim Announce FDA Breakthrough Device Designation for Prescription Digital Therapeutic to Treat Negative Symptoms of Schizophrenia
From Click Therapeutics, Inc.
Via Business Wire
Click Therapeutics To Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Click Therapeutics, Inc.
Via Business Wire
Click Therapeutics Announces Participation in November Investor Conferences
From Click Therapeutics, Inc.
Via Business Wire
Click Therapeutics Secures $20 Million Debt Financing from HSBC
From Click Therapeutics, Inc.
Via Business Wire
Click Therapeutics Announces Collaboration with Indivior to Develop and Commercialize Novel Prescription Digital Therapeutics in Substance Use Disorders
From Click Therapeutics, Inc.
Via Business Wire
Click Therapeutics Announces Participation in Upcoming Technology and Biotechnology Investor Events
From Click Therapeutics, Inc.
Via Business Wire
Click Therapeutics Launches Additional Randomized Clinical Study in Migraine, Conducted in Partnership with Syneos Health
From Click Therapeutics, Inc.
Via Business Wire
Click Therapeutics and Boehringer Ingelheim Initiate Pivotal Clinical Trial of Prescription Digital Therapeutics for the Treatment of Negative Symptoms in Schizophrenia
From Click Therapeutics, Inc.
Via Business Wire
Click Therapeutics Initiates Fully Remote Pivotal Trial Using Investigational Prescription Digital Therapeutics to Treat Episodic Migraine
From Click Therapeutics, Inc.
Via Business Wire
Click Therapeutics to Present at the 22nd Annual Needham Virtual Healthcare Conference
From Click Therapeutics, Inc.
Via Business Wire
Click Therapeutics Announces Participation in Upcoming Investor Conferences
From Click Therapeutics, Inc.
Via Business Wire
Click Therapeutics Shares 2022 Accomplishments and Development Progress in its Prescription Digital Therapeutics Programs
From Click Therapeutics, Inc.
Via Business Wire
Click Therapeutics Receives FDA Breakthrough Device Designation for Prescription Digital Therapeutic to Treat Episodic Migraine
From Click Therapeutics, Inc.
Via Business Wire
Click Therapeutics Announces Collaboration with the Massachusetts Medical Society to Enable Advancement in Medical Innovation
From Click Therapeutics, Inc.
Via Business Wire
Click Therapeutics Announces Participation in Upcoming Investor Conferences in November and December
From Click Therapeutics, Inc.
Via Business Wire
Click Therapeutics Announces Participation in Upcoming Investor Conferences
From Click Therapeutics, Inc.
Via Business Wire
Click Therapeutics to Present at the Canaccord Genuity 42nd Annual Growth Conference
From Click Therapeutics, Inc.
Via Business Wire
Click Therapeutics to Present at the H.C. Wainwright 1st Annual Mental Health Conference
From Click Therapeutics, Inc.
Via Business Wire
Click Therapeutics to Present at the Jefferies Healthcare Conference
From Click Therapeutics, Inc.
Via Business Wire
Click Therapeutics to Present at the UBS Global Healthcare Conference
From Click Therapeutics, Inc.
Via Business Wire
Click Therapeutics Closes $15 Million Debt Financing from Silicon Valley Bank
From Click Therapeutics, Inc.
Via Business Wire
Click Therapeutics to Present at Chardan’s Prescription Digital Therapeutics Summit
From Click Therapeutics, Inc.
Via Business Wire
Click Therapeutics Announces Formation of Scientific Advisory Board of Experts in Healthcare and Technology
From Click Therapeutics, Inc.
Via Business Wire
Click Therapeutics to Participate in the BTIG Digital Health Forum
From Click Therapeutics, Inc.
Via Business Wire
Click Therapeutics Completes $52 Million Series B Financing Co-Led by H.I.G. BioHealth Partners and Accelmed Partners
From Click Therapeutics, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.